222 related articles for article (PubMed ID: 19138754)
1. Tiotropium induced bronchodilation and protection from dynamic hyperinflation is independent of extent of emphysema in COPD.
Gelb AF; Taylor CF; Cassino C; Shinar CM; Schein MJ; Zamel N
Pulm Pharmacol Ther; 2009 Jun; 22(3):237-42. PubMed ID: 19138754
[TBL] [Abstract][Full Text] [Related]
2. Lack of protective effect of tiotropium vs induced dynamic hyperinflation in moderate COPD.
Gelb AF; Fraser C; Zamel N
Respir Med; 2011 May; 105(5):755-60. PubMed ID: 21159499
[TBL] [Abstract][Full Text] [Related]
3. Tiotropium and simplified detection of dynamic hyperinflation.
Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
[TBL] [Abstract][Full Text] [Related]
4. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.
Rossi A; Centanni S; Cerveri I; Gulotta C; Foresi A; Cazzola M; Brusasco V
Respir Med; 2012 Jan; 106(1):84-90. PubMed ID: 22035851
[TBL] [Abstract][Full Text] [Related]
6. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
van Noord JA; Aumann JL; Janssens E; Verhaert J; Smeets JJ; Mueller A; Cornelissen PJ
Chest; 2006 Mar; 129(3):509-17. PubMed ID: 16537846
[TBL] [Abstract][Full Text] [Related]
7. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
Celli B; ZuWallack R; Wang S; Kesten S
Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043
[TBL] [Abstract][Full Text] [Related]
8. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
9. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
Bateman ED; van Dyk M; Sagriotis A
Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
[TBL] [Abstract][Full Text] [Related]
10. Comparison of airway dimensions with once daily tiotropium plus indacaterol versus twice daily Advair(®) in chronic obstructive pulmonary disease.
Hoshino M; Ohtawa J; Akitsu K
Pulm Pharmacol Ther; 2015 Feb; 30():128-33. PubMed ID: 25183687
[TBL] [Abstract][Full Text] [Related]
11. Simplified detection of dynamic hyperinflation.
Gelb AF; Gutierrez CA; Weisman IM; Newsom R; Taylor CF; Zamel N
Chest; 2004 Dec; 126(6):1855-60. PubMed ID: 15596684
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease.
Fujimoto K; Kitaguchi Y; Kanda S; Urushihata K; Hanaoka M; Kubo K
Int J Chron Obstruct Pulmon Dis; 2011; 6():219-27. PubMed ID: 21660299
[TBL] [Abstract][Full Text] [Related]
13. Effects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with COPD.
Fujimoto K; Yoshiike F; Yasuo M; Kitaguchi Y; Urushihata K; Kubo K; Honda T
Respirology; 2007 Jan; 12(1):93-9. PubMed ID: 17207032
[TBL] [Abstract][Full Text] [Related]
14. A one-year trial of tiotropium Respimat plus usual therapy in COPD patients.
Bateman ED; Tashkin D; Siafakas N; Dahl R; Towse L; Massey D; Pavia D; Zhong NS
Respir Med; 2010 Oct; 104(10):1460-72. PubMed ID: 20620037
[TBL] [Abstract][Full Text] [Related]
15. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
16. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
17. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
[TBL] [Abstract][Full Text] [Related]
18. Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients.
Verkindre C; Fukuchi Y; Flémale A; Takeda A; Overend T; Prasad N; Dolker M
Respir Med; 2010 Oct; 104(10):1482-9. PubMed ID: 20541381
[TBL] [Abstract][Full Text] [Related]
19. Dynamic hyperinflation after metronome-paced hyperventilation in COPD--a 2 year follow-up.
Hannink J; Lahaije A; Bischoff E; van Helvoort H; Dekhuijzen R; Schermer T; Heijdra Y
Respir Med; 2010 Nov; 104(11):1700-5. PubMed ID: 20452759
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD.
Tanabe N; Muro S; Oguma T; Sato S; Kiyokawa H; Takahashi T; Kudo M; Kinose D; Kubo T; Hoshino Y; Ogawa E; Hirai T; Mishima M
COPD; 2012 Aug; 9(4):401-8. PubMed ID: 22509949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]